-
October 21, 2009
US advisers decline to push Gardasil for boys
WASHINGTON (Reuters) - U.S. vaccine advisers on Wednesday declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead for "permissive" use.
-
October 20, 2009
Free HPV vaccine curbs new cases of genital warts
NEW YORK (Reuters Health) - Since 2007, when free vaccination against HPV for young women became available, Australia has seen a rapid decline in new cases of genital warts, researchers say. HPV, or human papillomavirus, causes genital warts and cervical cancer.
-
October 9, 2009
Giving Gardasil to boys not cost effective: study
CHICAGO (Reuters) - Vaccinating boys against the virus that causes cervical cancer and genital warts does not appear to be cost-effective, U.S. researchers said on Thursday.
-
September 10, 2009
U.S. panel backs HPV vaccine for males
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday.
-
September 9, 2009
US FDA panel backs Glaxo cervical cancer vaccine
GAITHERSBURG, Md.(Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday.
-
September 4, 2009
Gardasil vaccine seems okay for men: FDA
WASHINGTON (Reuters) - Merck & Co's Gardasil vaccine appears to be safe and effective in preventing genital warts in young men and boys, a U.S. medical reviewer said in documents released on Friday.
-
August 25, 2009
Virus blamed for half of penile cancers
LONDON (Reuters) - A sexually transmitted virus that causes cervical cancer is also to blame for half of all cases of cancer of the penis, Spanish researchers said on Tuesday.
-
August 18, 2009
US researchers see few serious reactions to HPV vaccine
WASHINGTON (Reuters) - Adverse events like fainting or nausea remain rare among young women and girls given Merck and Co's Gardasil vaccine against cervical cancer, U.S. researchers reported on Tuesday.
-
July 23, 2009
Vaccine struggle embodies U.S. health reform battle
WASHINGTON (Reuters) - The confusion surrounding adult vaccination help illustrates some of the big problems looming for Congress as it struggles with healthcare reform legislation, doctors and health officials said on Wednesday.
-
July 6, 2009
HPV shot too costly for the Netherlands: study
NEW YORK (Reuters Health) - The vaccine against the virus responsible for most cases of cervical cancer would have to be a lot cheaper in order for it to be cost effective in the Netherlands, and probably in other countries where cases of cervical cancer and deaths due to the disease are relatively low, Dutch researchers report.
-
June 2, 2009
Cervical cancer vaccine benefits older women: study
WASHINGTON (Reuters) - Older women can benefit just as much as younger women from Merck's Gardasil vaccine against cervical cancer, researchers in Colombia reported on Monday.
-
May 19, 2009
Number of UK children with sex diseases soars
LONDON (Reuters Life!) - The number of British children being diagnosed with sexually transmitted infections (STIs) has soared in recent years, according to government figures.
-
April 2, 2009
Qiagen virus test cuts deaths from cervical cancer
BOSTON (Reuters) - A single test that looks for the virus that causes cervical cancer cut the death rate from the tumor in half, researchers in India reported on Wednesday.
-
March 26, 2009
Male circumcision cuts risk of cancer-causing virus
LONDON (Reuters) - Circumcision protects men from genital herpes and a virus that causes genital warts and cancer but it does not appear to guard against syphilis, U.S. and Ugandan researchers said on Wednesday.
-
March 23, 2009
Circumcision protects against genital wart virus
NEW YORK (Reuters Health) - A study of nearly 1000 men in three countries has yielded more evidence that circumcision helps protect against infection with human papillomavirus.
-
December 19, 2008
Indonesia's "tree man" faces new operations
TANJUNG JAYA, Indonesia (Reuters) - An Indonesian man dubbed the "tree man" because of the gnarled warts all over his body said on Friday his condition had worsened again although he still hoped to recover and find a job.
-
December 18, 2008
Male circumcision lowers cervical cancer risk: study
WASHINGTON (Reuters) - Three studies published on Wednesday add to evidence that circumcision can protect men from the deadly AIDS virus and the sexually transmitted virus that causes cervical cancer.
-
December 3, 2008
Allergic reactions to Gardasil uncommon: study
LONDON (Reuters) - A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses, Australian researchers said on Wednesday.
-
November 13, 2008
Cervical cancer vaccine can protect men from HPV
WASHINGTON (Reuters) - A vaccine designed to protect women and girls from cervical cancer caused by a virus that also causes genital warts may protect men, too, maker Merck and Co reported on Thursday.
-
November 3, 2008
Wart virus caused 25,000 cancers in 5 years
WASHINGTON (Reuters Life!) - The human wart virus HPV caused 25,000 cases of cancer in the United States between 1998 and 2003, including not only cervical cancer but also anal and mouth cancers, the U.S. Centers for Disease Control and Prevention reported on Monday.
-
October 27, 2008
Aggressive vaccine effort could cut cervical cancer
CHICAGO (Reuters) - An aggressive strategy of vaccinating older women against cervical cancer could deliver a crippling blow against the disease, cutting rates for that type of cancer in half for women through age 45, U.S. researchers said on Saturday.
-
October 24, 2008
British doctor chooses Gardasil shot over Cervarix
LONDON (Reuters) - Even though Britain chose GlaxoSmithKline's Cervarix for its cervical cancer vaccine program, many British doctors pick Merck and Co's Gardasil for their own daughters, a well-known physician said on Friday.
-
October 10, 2008
HPV infection rates similar in men and women
NEW YORK (Reuters Health) - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.
-
October 9, 2008
Quarter of adolescent U.S. girls received HPV
WASHINGTON (Reuters) - A quarter of girls aged 13 to 17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.
-
September 2, 2008
All types of sexual activity carry some STD risk
NEW YORK (Reuters Health) - Sexual activity other than intercourse carries some risk of sexually transmitted disease, and doctors should make sure their patients understand that, according to the American College of Obstetricians and Gynecologists (ACOG).
-
September 1, 2008
Study finds more allergic reactions after HPV jab
CHICAGO (Reuters) - Young women in Australia who got a vaccine to prevent cervical cancer were five to 20 times more likely to have a rare but severe allergic reaction than girls who got other vaccines in comparable school-based vaccination programs, researchers said on Monday.
-
July 22, 2008
FDA, CDC say Merck's Gardasil shot remains safe
WASHINGTON (Reuters) - A review of health problems reported after women and girls received Merck & Co's Gardasil vaccine shows it remains safe and effective for protecting against infection with a virus that causes cervical cancer, U.S. officials said on Tuesday.
-
July 15, 2008
Regular chlamydia tests urged for young people
LONDON (Reuters) - Young sexually active people should get themselves tested annually for the infection chlamydia and again every time they change partner, the Health Protection Agency said on Tuesday.
-
June 25, 2008
Merck cancer vaccine not cleared for older women
NEW YORK (Reuters) - U.S. regulators have told Merck & Co they cannot yet approve Merck's application to expand marketing of its cervical cancer vaccine Gardasil to an older group of women, the drugmaker said on Wednesday.
-
June 6, 2008
Green tea extract useful for genital warts
NEW YORK (Reuters Health) - A botanical ointment containing sinecatechins, a green tea extract, is an effective and well tolerated treatment for external genital and anal warts, results of a controlled study confirm.
-
May 21, 2008
Cancer risk soars in HIV-infected people: study
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
-
May 9, 2008
Mom's infection may boost epilepsy risk in offspring
NEW YORK (Reuters Health) - Exposure to certain maternal infections in the womb increases the odds of epilepsy in childhood, according to an analysis of data from a Danish study. Among the infections cited were cystitis (inflammation of the bladder), pyelonephritis (inflammation of the kidney and upper urinary tract), and vaginal yeast infection.
-
April 25, 2008
British students take up HPV vaccine, study finds
WASHINGTON (Reuters) - Up to 70 percent of British schoolgirls are likely to take up the offer of a vaccine to protect them against cervical cancer, despite doubts about other vaccines, researchers reported on Thursday.
-
March 19, 2008
Circumcised men no less likely to get sex diseases
NEW YORK (Reuters Health) - Circumcision does not appear to shield men from the types of sexually transmitted diseases (STDs) common in the developed world, according to new research from New Zealand.
-
March 12, 2008
Factors behind head and neck cancer revealed
WASHINGTON (Reuters) - There are two distinct culprits behind head and neck cancer -- the long-recognized heavy tobacco and alcohol use as well as a common sexually transmitted virus, researchers said on Tuesday.
-
March 11, 2008
Quarter of US teen girls have sex-related disease
WASHINGTON (Reuters) - More than one in four U.S. teen girls is infected with at least one sexually transmitted disease, and the rate is highest among blacks, the U.S. Centers for Disease Control and Prevention said on Tuesday.
-
February 21, 2008
Women risk HPV infection from first sex partner
NEW YORK (Reuters Health) - Women run a significant risk of acquiring human papillomavirus (HPV) from their very first sex partner, according to a new report.
-
November 5, 2007
Merck says Gardasil vaccine protects older women
CHICAGO (Reuters) - Gardasil, Merck's vaccine for preventing cervical cancer in girls and women aged 9 to 26, may offer protection for women up to age 45, the company said on Sunday.
-
October 26, 2007
All girls aged 12 to 13 to get cervical cancer jabs
LONDON (Reuters Life!) - All girls aged 12 to 13 in England will be vaccinated against the sexually transmitted virus that causes most cervical cancer cases, the government said Friday.
-
July 20, 2007
Genital wart virus goes away in most young women
NEW YORK (Reuters Health) - Young women commonly become infected with the human papillomavirus (HPV) soon after they start having sex, but the infection usually clears quickly, a new study shows.
-
June 28, 2007
Benefits of cervical cancer vaccine confirmed
LONDON (Reuters) - The experimental cervical cancer vaccine, Cervarix, is 90 percent effective in preventing precancerous viral infection for most cases of cervical cancer. GlaxoSmithKline Plc reported in the Lancet.
-
June 20, 2007
UK experts back use of cervical cancer vaccine
LONDON (Reuters) - British medical experts have recommended that girls aged 12 to 13 should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc and Sanofi-Aventis SA in Europe.
-
June 18, 2007
Swiss back cervical cancer shot, UK decision soon
LONDON (Reuters) - Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc and Sanofi-Aventis SA in Europe, the firms said on Monday.
-
March 26, 2007
Duct tape doesn't cure warts in adults: study
NEW YORK (Reuters Health) - Covering up a wart with transparent duct tape or moleskin, commonly referred to as occlusion therapy, hardly ever cures warts in adults, according to the results of a new study. Even when a treated wart resolves, it usually recurs within months, the investigators report.
-
March 16, 2007
Gardasil recommended in France for 14-year olds
PARIS (Reuters) - Gardasil, the recently launched cervical cancer vaccine marketed by Merck & Co Inc and Sanofi-Aventis SA, has been recommended in France for girls aged 14 years, the Sanofi Pasteur MSD joint venture said on Friday.